We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Margaret Hamburg has resigned as commissioner of the U.S. FDA, effective at the end of this month, ending a six-year tenure that saw the agency speed up its device approval process and increase its focus on personalized medicine. Under Hamburg’s watch, the agency’s budget rose by nearly $2 billion — from $2.7 billion in fiscal year 2009 to $4.5 billion this year. Read More